NEW Visitation Policy

COVID-19: Vaccines and Testing

COVID-19 Vaccine


Information for Adults

Now offering booster doses for individuals 18+ who received their Pfizer or Moderna COVID vaccine at least 6 months ago.

3rd Doses for Immunocompromised

3rd doses of both Pfizer and Moderna are available for individuals who are immunocompromised and received their 2nd dose greater than 28 days ago. Learn more

We offer multiple convenient ways for you to schedule an appointment:

  • Sign in or sign up for MyChart
  • Call 1-866-785-8537, option 7
  • Call your primary care provider or pediatrician

Schedule Now

Request for Vaccine Record

Lost your vaccine card or need electronic verification? Follow the attached steps.


Immunocompromised Individuals

Individuals ages 12 and up who are moderately to severely immunocompromised are advised to receive a third dose. They should receive the same brand of vaccine previously received (Pfizer or Moderna) with the second dose being a minimum of 28 days ago.

The individuals recommended for this third dose include people who have –

  • Been receiving active cancer treatment for tumors or cancers of the blood
  • Received an organ transplant and are taking medicine to suppress the immune system
  • Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
  • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response

Patients are encouraged to schedule an appointment via MyChart or call 1-866-STLUKES (785-8537), option 7.



FAQs on Variants

Why do viruses change?

Viruses constantly change through mutation, and new variants of a virus are expected to occur. A variant has one or more mutations that differentiate it from other variants in circulation. As expected, multiple variants of SARS-CoV-2 have been documented in the United States and globally throughout this pandemic. To inform local outbreak investigations and understand national trends, scientists compare genetic differences between viruses to identify variants and how they are related to each other.

What is the Delta Variant?

To assist with public discussions of variants, the World Health Organization proposed using labels consisting of the Greek Alphabet, e.g., Alpha, Beta, Gamma, as a practical way to discuss variants by non-scientific audiences. Delta is the B.1.617.2 "mutant" strain originating in India. Delta is now the predominant strain (>80%) in the US.

What are the variants currently in the United States?

Multiple variants are being monitored. Currently there are four notable variants in the United States:

  • B.1.1.7 (Alpha): This variant was first detected in the United States in December 2020. It was initially detected in the United Kingdom.
  • B.1.351 (Beta): This variant was first detected in the United States at the end of January 2021. It was initially detected in South Africa in December 2020.
  • P.1 (Gamma): This variant was first detected in the United States in January 2021. P.1 was initially identified in travelers from Brazil, who were tested during routine screening at an airport in Japan, in early January.
  • B.1.617.2 (Delta): This variant was first detected in the United States in March 2021. It was initially identified in India in December 2020.

These variants seem to spread more easily and quickly than other variants, which may lead to more cases of COVID-19. An increase in the number of cases will put more strain on healthcare resources, lead to more hospitalizations, and potentially more deaths.

So far, studies suggest that the current authorized vaccines work on the circulating variants. Scientists will continue to study these and other variants.

How is the Delta variant different?

The Delta variant is more contagious than other variants and it is more able to be spread by vaccinated individuals. Delta may cause more serious disease. People who have not been fully vaccinated against COVID-19 are most at risk.


Important Information for Kids and Adolescents

The Pfizer COVID-19 Vaccine is available for kids as young as 5. Vaccinating our children is a critical step in protecting them from COVID and its complications, but also in helping our children return to school, sports, camp and a general sense of normalcy.

All minors (under 18) will need to have a parent or guardian complete the Minor Consent Form. Consent forms will also be available onsite.

Individuals ages 13+ are able to register for their own St. Luke’s MyChart account and are able to schedule themselves. Individuals who are 5 - 12 years old will need a parent to create an account or schedule on their behalf.